Welcome to our dedicated page for REFLECT SCIENTIFIC news (Ticker: RSCF), a resource for investors and traders seeking the latest updates and insights on REFLECT SCIENTIFIC stock.
Reflect Scientific Inc. develops advanced cryogenic cooling and refrigeration technologies for customers that require ultra-low-temperature storage, rapid freezing, and cold-chain support. Company news commonly covers orders and installations for B-90 blast freezers, liquid nitrogen freezer systems, and other high-performance cooling products used by pharmaceutical, biotechnology, vaccine storage, and logistics customers.
Recurring updates also address patented cryogenic cooling applications for data centers and server rooms, operating-cost initiatives, contract manufacturing relationships, and OTC market disclosure status. The company’s announcements center on product adoption, precision temperature-control use cases, and business changes tied to its cryogenic technology platform.
Reflect Scientific (OTCQB: RSCF) has secured a $150,000 blanket order contract from a long-standing biotech client for consumable products. The contract spans five months, with revenue recognition split between Q4 2024 and Q1 2025. The partnership, which began in 2015, has supported the client through their development phase and commercialization of technology. The consumable products are part of Reflect Scientific's core offering to the biotechnology sector, where they provide cryogenic cooling solutions for biotechnology, pharmaceutical, medical, and transportation markets.
Reflect Scientific Inc. (OTCQB: RSCF) has secured a $225,000 order for its advanced blast freezing systems from a major Asia-based BioPharma company. This marks the eighth follow-on order from this client, indicating full adoption and standardization of Reflect Scientific's freezing technology. The order demonstrates the company's strong position in the global biotech market and the reliability of its products.
CEO Kim Boyce highlighted that this repeat order validates the superior performance and cost-effectiveness of their freezer systems. The sales from this order will be reflected in Reflect Scientific's third quarter 2024 financial results. This development signals positive momentum for the company as it expands its market presence and strengthens relationships with key industry players in the pharmaceutical and biotechnology sectors.
Reflect Scientific, Inc. announced sales of $105,000 from the L-80 MAX and L-80 Lite chillers, revolutionizing aluminum heat treatment in aerospace manufacturing. These chillers offer efficiency, precision, and safety, accelerating the quenching process and enhancing component durability. The success in aerospace opens opportunities for other industries. Reflect Scientific Inc. is actively exploring new sectors for their cooling technology.
Reflect Scientific Inc. (Symbol: RSCF) secured a $550,000 sale with a major biopharmaceutical company for its advanced freezing solutions. The sale includes multiple cutting-edge freezer systems shipped in the first and second quarters of 2024, marking a significant milestone in the relationship between Reflect Scientific and the buyer. The transaction highlights the growing demand for Reflect Scientific's innovative technologies and the trust major industry players have in their products, such as the T-90 Storage Freezer and T-160 Ultra Low Freezer. The sale reaffirms Reflect Scientific's commitment to providing reliable freezing solutions to the pharmaceutical industry.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.